The EGFR Exon 19 Mutant L747-A750 > P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

首页> 外文期刊>Journal of international management >The EGFR Exon 19 Mutant L747-A750 > P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

【24h】

The EGFR Exon 19 Mutant L747-A750 > P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

机译：EGFR外显子19突变体L747-A750> P对肺腺癌酪氨酸激酶抑制剂表现出明显的敏感性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of international management》 |2020年第2期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类管理学;
关键词

相似文献

外文文献
中文文献
专利

1. The EGFR Exon 19 Mutant L747-A750 > P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma [J] . Journal of international management . 2020,第2期

机译：EGFR外显子19突变体L747-A750> P对肺腺癌酪氨酸激酶抑制剂表现出明显的敏感性
2. The EGFR Exon 19 Mutant L747-A750 > P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma [J] . Di Federico Alessandro, Filippini Daria M., DallOlio Filippo G., Clinical cancer research: an official journal of the American Association for Cancer Research . 2020,第2期

机译：EGFR外显子19突变体L747-A750> P对肺腺癌酪氨酸激酶抑制剂表现出明显的敏感性
3. The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma [J] . Anna Truini, Jacqueline H. Starrett, Tyler Stewart, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第21期

机译：EGFR外显子19突变体L747-A750> P对肺腺癌酪氨酸激酶抑制剂表现出明显的敏感性
4. Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma [C] . Yeul Hong Kim, Hye Sook Kim, Jae Sook Sung, Molecular Medicine TRI-CON. . 2014

机译：下一代测序对非小细胞肺癌抗蛋白酶激酶抑制剂进行下一代测序检测的低负荷EGFR突变的预测疗效
5. RB1 Loss Accelerates acquired Therapeutic Resistance in EGFR Mutant Lung Adenocarcinoma via Lineage Plasticity [D] . Zhang, Letian. 2021

机译：RB1损失通过谱系可塑性加速EGFR突变体肺腺癌的获得性抗性
6. Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [O] . Wen Gao, Jing He, Shi-Dai Jin, 2019

机译：非小细胞肺癌患者对一线表皮生长因子受体酪氨酸激酶抑制剂耐药后初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子19缺失与T790M突变频率的关系
7. The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma—Letter [O] . Alessandro Di Federico, Daria M. Filippini, Filippo G. DallOlio, 2020

机译：EGFR外显子19突变体L747-A750> P对肺腺癌 - 字母的酪氨酸激酶抑制剂表现出明显的敏感性

The EGFR Exon 19 Mutant L747-A750 > P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

著录项

相似文献

相关主题

期刊订阅